RPS makes new recommendations for pharmacist independent prescribers
RPS wants to see increased use of pharmacist independent prescribers in the UK
Read More
Tag: RPS
NHS prescription charges set to rise in England
Charge will increase to £9.35 per single prescription item from 1 April 2021
Read More
RPS calls for prevention of counterfeit medicines in UK’s supply chain
In a letter to Health Secretary Matt Hancock the RPS called for urgent action
Read More
Pharmacists should have greater powers to ensure meds access, says RPS
The proposals would enable pharmacists to amend the strength and formulation of the medicine dispensed or supply a generic alternative
Read More
More than half of UK adults self-diagnosing, survey finds
More than half (51 percent) of adults in the UK self-diagnose when feeling unwell or experiencing a medical symptom, according to findings of a national survey by YouGov released by the Royal Pharmaceutical Society.
Read More
RPS launches campaign to improve use of pharmacists
The Royal Pharmaceutical Society is encouraging better use of pharmacists in the management of patients with long-term conditions, in a new nationwide campaign designed to improve care.
Read More
Gov’t announces cuts to community pharmacy budget
Health Minister David Mowat has announced that community pharmacy will see its budget slashed by 4 percent to £2.7 billion in the year 2016/17, with further cuts planned thereafter.
Read More
Pharmacy funding cuts put on hold
The government has pushed the pause button on plans to implement a 6 percent cut to community pharmacy funding from October.
Read More
Community pharmacy unveils its vision for the future
Pharmacy chiefs have published their vision for the future of community pharmacy in the UK, laying out a new roadmap to radically enhance and expand personalised care, support and wellbeing services provided by the sector.
Read More
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
